An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

September 27, 2023 updated by: University of California, Los Angeles

This study plans to develop an integrated treatment for comorbid post-traumatic stress disorder (PTSD) and substance abuse (SA) in adolescents. The investigators aim to develop a treatment approach that is community-friendly, well-tolerated, and deliverable by substance abuse counselors (SAC) in outpatient settings. The proposed Trauma-Focused Substance Abuse Treatment (TFSAT) aims to reduce PTSD symptoms and substance use and build coping skills. The investigators propose to adapt an evidence-based trauma program, Cognitive-Behavioral Intervention for Trauma in Schools (CBITS), for adolescent substance abusers (ASAbusers); to assess the acceptability and feasibility of the integrated approach; and to pilot test the new program against standard care.

The investigators hypothesize that the intervention group, compared to the control group, will reduce substance use and symptoms for traumatic stress.

Study Overview

Study Type

Interventional

Enrollment (Actual)

117

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90032
        • Behavioral Health Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: Youth

  • Between ages of 13 & 19;
  • meeting DSM IV criteria for substance abuse/dependence and PTSD;
  • previously enrolled at recruitment site for at least 2 weeks;
  • parent/guardian provides permission for minors to participate.

Exclusion Criteria: Youth

  • Not within the specified age range;
  • presence of organic brain damage;
  • inability to understand enrollment forms (e.g. Informed Assent/Consent Form)

Inclusion Criteria: Parents/Guardians

  • Age 18 or above;
  • parents/guardians of youth who meets inclusion criteria.

Exclusion Criteria: Parents/Guardians

  • presence of organic brain damage.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of Care
The Standard of Care condition includes: 1) an individual session with the counselor, once per week; 2) a treatment group with the counselor, twice per week; and 3) parents of youth are invited to attend parent-only educational sessions weekly.
Experimental: Trauma-focused Substance Abuse Intervention
See Intervention Arm description.
An integrated treatment approach to reduce substance use and PTSD symptoms. The intervention program includes: 1) 1-2 individual sessions during which youth talk about the trauma, during the course of the intervention program; 2) 16 group sessions for youth; 3) 2 conjoint sessions with parents to improve communication and problem-solving skills; and 4) 2 parent-education group sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timeline Follow-back (TFLB) Assessment of Substance Use
Time Frame: Participants will be followed for an expected average of 12 weeks.
The TLFB uses a blank calendar form and a series of questions to cue recall of alcohol and drug (AOD) use. The investigators will use the TLFB interview technique to assess AOD use weekly.
Participants will be followed for an expected average of 12 weeks.
Urine Toxicology Screen (UTS)
Time Frame: Participants will be followed for an expected average of 12 weeks.
Urine samples will be collected twice per week at the treatment site to ensure validity of self-reports.
Participants will be followed for an expected average of 12 weeks.
Child PTSD Symptom Scale (CPSS)
Time Frame: Change from Baseline in Child PTSD Symptom Scale at 8 weeks and change from Baseline in Child PTSD Symptom Scale at 12 weeks.
The CPSS will assess for severity of traumatic stress symptoms.
Change from Baseline in Child PTSD Symptom Scale at 8 weeks and change from Baseline in Child PTSD Symptom Scale at 12 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Post-Trauma Attitudes Scale (C-PTAS)
Time Frame: Baseline & 8 weeks & 3 months
The C-PTAS will be used to assess trauma-related attitudes and beliefs.
Baseline & 8 weeks & 3 months
Strengths & Difficulties Questionnaire (SDQ)
Time Frame: Baseline & 8 weeks & 3 months
The SDQ will be used to assess parent-report of behavioral problems.
Baseline & 8 weeks & 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nancy S Wu, MD, University of California, Los Angeles

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

July 18, 2012

First Submitted That Met QC Criteria

April 1, 2013

First Posted (Estimated)

April 8, 2013

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 27, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 1R34DA031301 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Clinical Trials on Trauma-focused Substance Abuse Intervention

Subscribe